Peter K. Schulz-Knappe
Keine laufenden Positionen mehr
Karriereverlauf von Peter K. Schulz-Knappe
Ehemalige bekannte Positionen von Peter K. Schulz-Knappe
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| IMMUNOVIA AB | Technik-/Wissenschafts-/F&E-Leiter | - | 31.08.2020 |
| PROTEOME SCIENCES PLC | Technik-/Wissenschafts-/F&E-Leiter | 05.10.2009 | 31.12.2009 |
Protagen AG
 Protagen AG BiotechnologyHealth Technology Protagen AG specializes in the development of novel diagnostic and companion diagnostic tests. Its products and services include GMP analyses, protein identification and analyses, proteome studies, UNIchip, clone and array, Bio-IT, Modiro as well as ProteinScape and Solver. The company was founded by Stefan Müllner, Helmut E. Meyer, Petra Weingarten and Martin Blüggel in 1997 and is headquartered in Dortmund, Germany. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2010 | - |
| Corporate Officer/Principal | 05.05.2010 | 23.12.2014 | |
Digilab BioVisioN GmbH
 Digilab BioVisioN GmbH Miscellaneous Commercial ServicesCommercial Services Digilab BioVisioN GmbH provides research services in the area of peptide analysis to health care by discovering and developing novel substances and methods to diagnose and treat human diseases. Its partners include Roche Diagnostics GmbH for the discovery of novel biomarker candidates of Alzheimer's disease and Novo Nordisk for the search for novel therapeutic approaches in type 2 diabetes. The company was founded in 1997 and is headquartered in Hannover, Germany. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.1997 | - |
| Gründer | 01.11.1997 | - |
Statistik
International
| Deutschland | 3 |
| Vereinigtes Königreich | 2 |
| Schweden | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 4 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 4 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PROTEOME SCIENCES PLC | Health Technology |
| IMMUNOVIA AB | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Digilab BioVisioN GmbH
Digilab BioVisioN GmbH Miscellaneous Commercial ServicesCommercial Services Digilab BioVisioN GmbH provides research services in the area of peptide analysis to health care by discovering and developing novel substances and methods to diagnose and treat human diseases. Its partners include Roche Diagnostics GmbH for the discovery of novel biomarker candidates of Alzheimer's disease and Novo Nordisk for the search for novel therapeutic approaches in type 2 diabetes. The company was founded in 1997 and is headquartered in Hannover, Germany. | Commercial Services |
Protagen AG
Protagen AG BiotechnologyHealth Technology Protagen AG specializes in the development of novel diagnostic and companion diagnostic tests. Its products and services include GMP analyses, protein identification and analyses, proteome studies, UNIchip, clone and array, Bio-IT, Modiro as well as ProteinScape and Solver. The company was founded by Stefan Müllner, Helmut E. Meyer, Petra Weingarten and Martin Blüggel in 1997 and is headquartered in Dortmund, Germany. | Health Technology |
- Börse
- Insiders
- Peter K. Schulz-Knappe
- Erfahrung
